Myasthenia gravis echocardiography or ultrasound

Revision as of 18:39, 28 November 2018 by Fahimeh Shojaei (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Myasthenia gravis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myasthenia Gravis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myasthenia gravis echocardiography or ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myasthenia gravis echocardiography or ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myasthenia gravis echocardiography or ultrasound

CDC on Myasthenia gravis echocardiography or ultrasound

Myasthenia gravis echocardiography or ultrasound in the news

Blogs on Myasthenia gravis echocardiography or ultrasound

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Myasthenia gravis echocardiography or ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Some abnormalities has been reported in these patients. One of them is LV diastolic filling defects which improve with AChE inhibitors.

Echocardiography or Ultrasound

  • Echocardiography may be helpful in the diagnosis of cardiac involvement of myasthenia gravis. Since there are several cholinergic mechanisms in heart, this organ can be affected by Myasthenia gravis.[1][2][3]
  • Some abnormalities has been reported in these patients. One of them is LV diastolic filling defects which improve with AChE inhibitors.[4]

References

  1. MENDELOW H, GENKINS G (1954). "Studies in myasthenia gravis: cardiac and associated pathology". J Mt Sinai Hosp N Y. 21 (4): 218–25. PMID 13212376.
  2. Buccino RA, Sonnenblick EH, Cooper T, Braunwald E (December 1966). "Direct positive inotropic effect of acetylcholine on myocardium. Evidence for multiple cholinergic receptors in the heart". Circ. Res. 19 (6): 1097–108. PMID 5928546.
  3. Jacobowitz D, Cooper T, Barner HB (March 1967). "Histochemical and chemical studies of the localization of adrenergic and cholinergic nerves in normal and denervated cat hearts". Circ. Res. 20 (3): 289–98. PMID 6025610.
  4. Johannessen KA, Mygland A, Gilhus NE, Aarli J, Vik-Mo H (January 1992). "Left ventricular function in myasthenia gravis". Am. J. Cardiol. 69 (1): 129–32. PMID 1729861.


Template:WH Template:WS